You are here: Industry Insights > job cuts

News List

Vical slashes staff after culling phase II antifungal pharmaphorum
February 22, 2019
US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug VL-2397, its last remaining clinical-stage asset.....
Eli Lilly plots 250 job cuts in €100M revamp of French plant fiercepharma
January 13, 2019
Boehringer Ingelheim and Sanofi aren't the only pharma companies chopping jobs in France. Now, Eli Lilly says it's cutting 250 positions as part of a "modernization" effort at a plant in Fegersheim.
Boehringer follows Sanofi with job cuts in France pharmaphorum
December 12, 2018
Boehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more than 300 jobs, adding to several hundred losses at Sanofi last week.
Bayer to cut loose animal health, consumer brands and 12,000 jobs in huge shakeup fiercepharma
December 04, 2018
At last, after back-and-forth speculation and denials, Bayer has revealed it will indeed cast off its animal health unit, a few consumer health brands and 12,000 jobs amid a large-scale restructuring that touches every area of its business.
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threat fiercepharma
November 02, 2018
Diabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have cut about 1,300 employees by the end of 2018.
Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure fiercepharma
September 29, 2018
Days after swinging the ax on 400 R&D jobs in China and Denmark, diabetes giant Novo Nordisk is laying off again—this time in the U.S.
Gemphire cuts 33% of staff, including CFO, CMO fiercebiotech
September 27, 2018
The FDA placed a partial clinical hold on gemcabene in 2004, requesting preclinical data to move forward with an end of phase 2 meeting in dyslipidemia indications.
Novartis, axing 19% of its workforce, faces big challenges with thinned ranks fiercepharma
September 26, 2018
When Novartis created its business services unit in 2014, creating $3 billion in what the company called “productivity gains” as it reduced the costs associated with its back-office operations.
Akcea lays off 10% of staff following volanesorsen rejection fiercebiotech
September 10, 2018
Akcea had built its headcount up to 270 in anticipation of bringing volanesorsen to market.
With drugs pipeline in focus, Bayer considers job cuts financialexpress
September 05, 2018
The savings that Bayer – the inventor of aspirin and maker of Yasmin birth control pills – could make as part of the overhaul would give it financial wiggle room as it competes with larger rivals to buy the right to promising treatments from biotech firms

Previous page 1 2 Next page